company background image
MEGA logo

Mega Lifesciences SET:MEGA Stock Report

Last Price

฿37.00

Market Cap

฿32.3b

7D

1.4%

1Y

-3.9%

Updated

21 Jul, 2024

Data

Company Financials +

Mega Lifesciences Public Company Limited

SET:MEGA Stock Report

Market Cap: ฿32.3b

MEGA Stock Overview

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.

MEGA fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Mega Lifesciences Public Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mega Lifesciences
Historical stock prices
Current Share Price฿37.00
52 Week High฿46.75
52 Week Low฿35.75
Beta0.40
11 Month Change1.37%
3 Month Change-9.20%
1 Year Change-3.90%
33 Year Change-10.30%
5 Year Change2.78%
Change since IPO73.71%

Recent News & Updates

Recent updates

Shareholder Returns

MEGATH PharmaceuticalsTH Market
7D1.4%-0.4%-1.2%
1Y-3.9%7.1%-14.1%

Return vs Industry: MEGA underperformed the TH Pharmaceuticals industry which returned 7.1% over the past year.

Return vs Market: MEGA exceeded the TH Market which returned -14.1% over the past year.

Price Volatility

Is MEGA's price volatile compared to industry and market?
MEGA volatility
MEGA Average Weekly Movement2.6%
Pharmaceuticals Industry Average Movement5.1%
Market Average Movement4.4%
10% most volatile stocks in TH Market9.4%
10% least volatile stocks in TH Market2.2%

Stable Share Price: MEGA has not had significant price volatility in the past 3 months.

Volatility Over Time: MEGA's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982n/aVivek Dhawanwww.megawecare.com

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products.

Mega Lifesciences Public Company Limited Fundamentals Summary

How do Mega Lifesciences's earnings and revenue compare to its market cap?
MEGA fundamental statistics
Market cap฿32.26b
Earnings (TTM)฿2.02b
Revenue (TTM)฿15.72b

16.0x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MEGA income statement (TTM)
Revenue฿15.72b
Cost of Revenue฿8.47b
Gross Profit฿7.25b
Other Expenses฿5.23b
Earnings฿2.02b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 13, 2024

Earnings per share (EPS)2.31
Gross Margin46.13%
Net Profit Margin12.83%
Debt/Equity Ratio0.9%

How did MEGA perform over the long term?

See historical performance and comparison

Dividends

4.3%

Current Dividend Yield

69%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.